Minimal Change Esophagitis: Prospective Comparison of Endoscopic and Histological Markers between Patients with Non-Erosive Reflux Disease and Normal Controls Using Magnifying Endoscopy

Introduction: More than half the patients with gastroesophageal reflux disease (GERD) show no endoscopic abnormality or minimal change esophagitis (non-erosive reflux disease, NERD). We investigated the value of endoscopic and histological markers for the prediction of NERD before and after treatmen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Digestive diseases (Basel) 2004-01, Vol.22 (2), p.221-227
Hauptverfasser: Kiesslich, R., Kanzler, S., Vieth, M., Moehler, M., Neidig, J., Thanka Nadar, B.J., Schilling, D., Burg, J., Nafe, B., Neurath, M.F., Galle, P.R.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 227
container_issue 2
container_start_page 221
container_title Digestive diseases (Basel)
container_volume 22
creator Kiesslich, R.
Kanzler, S.
Vieth, M.
Moehler, M.
Neidig, J.
Thanka Nadar, B.J.
Schilling, D.
Burg, J.
Nafe, B.
Neurath, M.F.
Galle, P.R.
description Introduction: More than half the patients with gastroesophageal reflux disease (GERD) show no endoscopic abnormality or minimal change esophagitis (non-erosive reflux disease, NERD). We investigated the value of endoscopic and histological markers for the prediction of NERD before and after treatment with 20 mg esomeprazole. Methods: Between July and October 2002, consecutive patients presenting for upper endoscopy were stratified into GERD and non-reflux patients (control group) with the help of a questionnaire. The endoscopist was blind to the presence of reflux symptoms. Using magnifying endoscopes minimal change esophagitis was defined by the presence of vascular injection or vascular spots above the Z-line, villous mucosal surface and islands of squamous cell epithelium below the Z-line. Targeted and random biopsies were taken below and above the Z-line. Patients with endoscopically visible classical signs of esophagitis (Los Angeles A–D) or histologically proven Barrett’s esophagus were not further investigated in the study (drop out). The esophageal specimens were histologically evaluated for erosions, infiltration with leukocytes, hyperplasia of basal cells and length of papillae. Patients with NERD were treated with 20 mg esomeprazole/day for 4 weeks and reevaluated by endoscopy as described before. Results: 39 patients with heartburn and 39 patients without reflux symptoms (controls) were finally included in the analysis (per protocol). Patients with NERD significantly (p = 0.005) more often showed endoscopic signs of minimal change esophagitis (27/39) than the control group (8/39). An increased length of papillae (14/39 versus 2/39; p = 0.005) and basal cell hyperplasia (17/39 versus 4/39; p = 0.009) were significantly more common in the heartburn group. After treatment with esomeprazole, no significant endoscopic or histological differences between the NERD and control group could be observed. Conclusions: Minimal change esophagitis can be seen with high resolution magnifying endoscopy. By combining endoscopic and histological markers NERD can be predicted with a sensitivity of 62% and a specificity of 74%. Treatment with esomeprazole for 4 weeks reverses the slight alterations to normal.
doi_str_mv 10.1159/000080323
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_15383765</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>66901253</sourcerecordid><originalsourceid>FETCH-LOGICAL-c328t-77152a9552d11fa3d3841f481c4792a8258f26a9fc7c8d472715a9d8311cf68b3</originalsourceid><addsrcrecordid>eNptkc1vFCEYh_Erdlt78GxiiAcTD6N8DAN4M7urbdLWxtjzhGVgFjsLI7DW_dP872Q_Wi9ygYSH5-V9fwC8xOg9xkx-QGUJRAl9BI4pxQJh3FD0GExwTXAlBWdPwKnkggrEGBe1pE_BBBHGK8IZPQLHKf1AqJh48xwcYUYF5Q2bgD-XzruVGuB0qXxv4DyFcal6l136CK9jSKPR2f0ycBpWo4ouBQ-DhXPfhaTD6DRUvoNnLuUwhN7pYrpU8dbEBBcm3xnj4bXKzvic4J3LS3gVfDUv3q3zm7HD-jecuWRUMjvTVYi73wSfYxgSvEnO90XZe2c32-N95c0L8MyqIZnTw34Cbj7Pv0_PqouvX86nny4qTYnIFeeYESUZIx3GVtGOihrbWmBdc0mUIExY0ihpNdeiqzkpvJKdoBhr24gFPQFv994xhp9rk3K7ckmbYVDehHVqm0YiTBgt4Ls9qEt7KRrbjrGMNm5ajNptiO1DiIV9fZCuFyvT_SMPwRTg1R64VbE38QG4f_7mv7ez2fkOaMfO0r9FAamy</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66901253</pqid></control><display><type>article</type><title>Minimal Change Esophagitis: Prospective Comparison of Endoscopic and Histological Markers between Patients with Non-Erosive Reflux Disease and Normal Controls Using Magnifying Endoscopy</title><source>MEDLINE</source><source>Karger Journals</source><source>Alma/SFX Local Collection</source><creator>Kiesslich, R. ; Kanzler, S. ; Vieth, M. ; Moehler, M. ; Neidig, J. ; Thanka Nadar, B.J. ; Schilling, D. ; Burg, J. ; Nafe, B. ; Neurath, M.F. ; Galle, P.R.</creator><creatorcontrib>Kiesslich, R. ; Kanzler, S. ; Vieth, M. ; Moehler, M. ; Neidig, J. ; Thanka Nadar, B.J. ; Schilling, D. ; Burg, J. ; Nafe, B. ; Neurath, M.F. ; Galle, P.R.</creatorcontrib><description>Introduction: More than half the patients with gastroesophageal reflux disease (GERD) show no endoscopic abnormality or minimal change esophagitis (non-erosive reflux disease, NERD). We investigated the value of endoscopic and histological markers for the prediction of NERD before and after treatment with 20 mg esomeprazole. Methods: Between July and October 2002, consecutive patients presenting for upper endoscopy were stratified into GERD and non-reflux patients (control group) with the help of a questionnaire. The endoscopist was blind to the presence of reflux symptoms. Using magnifying endoscopes minimal change esophagitis was defined by the presence of vascular injection or vascular spots above the Z-line, villous mucosal surface and islands of squamous cell epithelium below the Z-line. Targeted and random biopsies were taken below and above the Z-line. Patients with endoscopically visible classical signs of esophagitis (Los Angeles A–D) or histologically proven Barrett’s esophagus were not further investigated in the study (drop out). The esophageal specimens were histologically evaluated for erosions, infiltration with leukocytes, hyperplasia of basal cells and length of papillae. Patients with NERD were treated with 20 mg esomeprazole/day for 4 weeks and reevaluated by endoscopy as described before. Results: 39 patients with heartburn and 39 patients without reflux symptoms (controls) were finally included in the analysis (per protocol). Patients with NERD significantly (p = 0.005) more often showed endoscopic signs of minimal change esophagitis (27/39) than the control group (8/39). An increased length of papillae (14/39 versus 2/39; p = 0.005) and basal cell hyperplasia (17/39 versus 4/39; p = 0.009) were significantly more common in the heartburn group. After treatment with esomeprazole, no significant endoscopic or histological differences between the NERD and control group could be observed. Conclusions: Minimal change esophagitis can be seen with high resolution magnifying endoscopy. By combining endoscopic and histological markers NERD can be predicted with a sensitivity of 62% and a specificity of 74%. Treatment with esomeprazole for 4 weeks reverses the slight alterations to normal.</description><identifier>ISSN: 0257-2753</identifier><identifier>ISBN: 9783805578493</identifier><identifier>ISBN: 3805578490</identifier><identifier>EISSN: 1421-9875</identifier><identifier>EISBN: 3318011630</identifier><identifier>EISBN: 9783318011630</identifier><identifier>DOI: 10.1159/000080323</identifier><identifier>PMID: 15383765</identifier><language>eng</language><publisher>Basel, Switzerland</publisher><subject>Anti-Ulcer Agents - administration &amp; dosage ; Anti-Ulcer Agents - therapeutic use ; Biopsy - methods ; Case-Control Studies ; Enzyme Inhibitors - administration &amp; dosage ; Enzyme Inhibitors - therapeutic use ; Esomeprazole - administration &amp; dosage ; Esomeprazole - therapeutic use ; Esophagitis - diagnosis ; Esophagitis - drug therapy ; Esophagitis - pathology ; Esophagoscopy - methods ; Female ; Humans ; Male ; Middle Aged ; Original Paper ; Predictive Value of Tests ; Prospective Studies ; Proton Pump Inhibitors ; Sensitivity and Specificity</subject><ispartof>Digestive diseases (Basel), 2004-01, Vol.22 (2), p.221-227</ispartof><rights>2004 S. Karger AG, Basel</rights><rights>Copyright 2004 S. Karger AG, Basel</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c328t-77152a9552d11fa3d3841f481c4792a8258f26a9fc7c8d472715a9d8311cf68b3</citedby><cites>FETCH-LOGICAL-c328t-77152a9552d11fa3d3841f481c4792a8258f26a9fc7c8d472715a9d8311cf68b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,2423,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15383765$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kiesslich, R.</creatorcontrib><creatorcontrib>Kanzler, S.</creatorcontrib><creatorcontrib>Vieth, M.</creatorcontrib><creatorcontrib>Moehler, M.</creatorcontrib><creatorcontrib>Neidig, J.</creatorcontrib><creatorcontrib>Thanka Nadar, B.J.</creatorcontrib><creatorcontrib>Schilling, D.</creatorcontrib><creatorcontrib>Burg, J.</creatorcontrib><creatorcontrib>Nafe, B.</creatorcontrib><creatorcontrib>Neurath, M.F.</creatorcontrib><creatorcontrib>Galle, P.R.</creatorcontrib><title>Minimal Change Esophagitis: Prospective Comparison of Endoscopic and Histological Markers between Patients with Non-Erosive Reflux Disease and Normal Controls Using Magnifying Endoscopy</title><title>Digestive diseases (Basel)</title><addtitle>Dig Dis</addtitle><description>Introduction: More than half the patients with gastroesophageal reflux disease (GERD) show no endoscopic abnormality or minimal change esophagitis (non-erosive reflux disease, NERD). We investigated the value of endoscopic and histological markers for the prediction of NERD before and after treatment with 20 mg esomeprazole. Methods: Between July and October 2002, consecutive patients presenting for upper endoscopy were stratified into GERD and non-reflux patients (control group) with the help of a questionnaire. The endoscopist was blind to the presence of reflux symptoms. Using magnifying endoscopes minimal change esophagitis was defined by the presence of vascular injection or vascular spots above the Z-line, villous mucosal surface and islands of squamous cell epithelium below the Z-line. Targeted and random biopsies were taken below and above the Z-line. Patients with endoscopically visible classical signs of esophagitis (Los Angeles A–D) or histologically proven Barrett’s esophagus were not further investigated in the study (drop out). The esophageal specimens were histologically evaluated for erosions, infiltration with leukocytes, hyperplasia of basal cells and length of papillae. Patients with NERD were treated with 20 mg esomeprazole/day for 4 weeks and reevaluated by endoscopy as described before. Results: 39 patients with heartburn and 39 patients without reflux symptoms (controls) were finally included in the analysis (per protocol). Patients with NERD significantly (p = 0.005) more often showed endoscopic signs of minimal change esophagitis (27/39) than the control group (8/39). An increased length of papillae (14/39 versus 2/39; p = 0.005) and basal cell hyperplasia (17/39 versus 4/39; p = 0.009) were significantly more common in the heartburn group. After treatment with esomeprazole, no significant endoscopic or histological differences between the NERD and control group could be observed. Conclusions: Minimal change esophagitis can be seen with high resolution magnifying endoscopy. By combining endoscopic and histological markers NERD can be predicted with a sensitivity of 62% and a specificity of 74%. Treatment with esomeprazole for 4 weeks reverses the slight alterations to normal.</description><subject>Anti-Ulcer Agents - administration &amp; dosage</subject><subject>Anti-Ulcer Agents - therapeutic use</subject><subject>Biopsy - methods</subject><subject>Case-Control Studies</subject><subject>Enzyme Inhibitors - administration &amp; dosage</subject><subject>Enzyme Inhibitors - therapeutic use</subject><subject>Esomeprazole - administration &amp; dosage</subject><subject>Esomeprazole - therapeutic use</subject><subject>Esophagitis - diagnosis</subject><subject>Esophagitis - drug therapy</subject><subject>Esophagitis - pathology</subject><subject>Esophagoscopy - methods</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Original Paper</subject><subject>Predictive Value of Tests</subject><subject>Prospective Studies</subject><subject>Proton Pump Inhibitors</subject><subject>Sensitivity and Specificity</subject><issn>0257-2753</issn><issn>1421-9875</issn><isbn>9783805578493</isbn><isbn>3805578490</isbn><isbn>3318011630</isbn><isbn>9783318011630</isbn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkc1vFCEYh_Erdlt78GxiiAcTD6N8DAN4M7urbdLWxtjzhGVgFjsLI7DW_dP872Q_Wi9ygYSH5-V9fwC8xOg9xkx-QGUJRAl9BI4pxQJh3FD0GExwTXAlBWdPwKnkggrEGBe1pE_BBBHGK8IZPQLHKf1AqJh48xwcYUYF5Q2bgD-XzruVGuB0qXxv4DyFcal6l136CK9jSKPR2f0ycBpWo4ouBQ-DhXPfhaTD6DRUvoNnLuUwhN7pYrpU8dbEBBcm3xnj4bXKzvic4J3LS3gVfDUv3q3zm7HD-jecuWRUMjvTVYi73wSfYxgSvEnO90XZe2c32-N95c0L8MyqIZnTw34Cbj7Pv0_PqouvX86nny4qTYnIFeeYESUZIx3GVtGOihrbWmBdc0mUIExY0ihpNdeiqzkpvJKdoBhr24gFPQFv994xhp9rk3K7ckmbYVDehHVqm0YiTBgt4Ls9qEt7KRrbjrGMNm5ajNptiO1DiIV9fZCuFyvT_SMPwRTg1R64VbE38QG4f_7mv7ez2fkOaMfO0r9FAamy</recordid><startdate>20040101</startdate><enddate>20040101</enddate><creator>Kiesslich, R.</creator><creator>Kanzler, S.</creator><creator>Vieth, M.</creator><creator>Moehler, M.</creator><creator>Neidig, J.</creator><creator>Thanka Nadar, B.J.</creator><creator>Schilling, D.</creator><creator>Burg, J.</creator><creator>Nafe, B.</creator><creator>Neurath, M.F.</creator><creator>Galle, P.R.</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20040101</creationdate><title>Minimal Change Esophagitis: Prospective Comparison of Endoscopic and Histological Markers between Patients with Non-Erosive Reflux Disease and Normal Controls Using Magnifying Endoscopy</title><author>Kiesslich, R. ; Kanzler, S. ; Vieth, M. ; Moehler, M. ; Neidig, J. ; Thanka Nadar, B.J. ; Schilling, D. ; Burg, J. ; Nafe, B. ; Neurath, M.F. ; Galle, P.R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c328t-77152a9552d11fa3d3841f481c4792a8258f26a9fc7c8d472715a9d8311cf68b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Anti-Ulcer Agents - administration &amp; dosage</topic><topic>Anti-Ulcer Agents - therapeutic use</topic><topic>Biopsy - methods</topic><topic>Case-Control Studies</topic><topic>Enzyme Inhibitors - administration &amp; dosage</topic><topic>Enzyme Inhibitors - therapeutic use</topic><topic>Esomeprazole - administration &amp; dosage</topic><topic>Esomeprazole - therapeutic use</topic><topic>Esophagitis - diagnosis</topic><topic>Esophagitis - drug therapy</topic><topic>Esophagitis - pathology</topic><topic>Esophagoscopy - methods</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Original Paper</topic><topic>Predictive Value of Tests</topic><topic>Prospective Studies</topic><topic>Proton Pump Inhibitors</topic><topic>Sensitivity and Specificity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kiesslich, R.</creatorcontrib><creatorcontrib>Kanzler, S.</creatorcontrib><creatorcontrib>Vieth, M.</creatorcontrib><creatorcontrib>Moehler, M.</creatorcontrib><creatorcontrib>Neidig, J.</creatorcontrib><creatorcontrib>Thanka Nadar, B.J.</creatorcontrib><creatorcontrib>Schilling, D.</creatorcontrib><creatorcontrib>Burg, J.</creatorcontrib><creatorcontrib>Nafe, B.</creatorcontrib><creatorcontrib>Neurath, M.F.</creatorcontrib><creatorcontrib>Galle, P.R.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Digestive diseases (Basel)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kiesslich, R.</au><au>Kanzler, S.</au><au>Vieth, M.</au><au>Moehler, M.</au><au>Neidig, J.</au><au>Thanka Nadar, B.J.</au><au>Schilling, D.</au><au>Burg, J.</au><au>Nafe, B.</au><au>Neurath, M.F.</au><au>Galle, P.R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Minimal Change Esophagitis: Prospective Comparison of Endoscopic and Histological Markers between Patients with Non-Erosive Reflux Disease and Normal Controls Using Magnifying Endoscopy</atitle><jtitle>Digestive diseases (Basel)</jtitle><addtitle>Dig Dis</addtitle><date>2004-01-01</date><risdate>2004</risdate><volume>22</volume><issue>2</issue><spage>221</spage><epage>227</epage><pages>221-227</pages><issn>0257-2753</issn><eissn>1421-9875</eissn><isbn>9783805578493</isbn><isbn>3805578490</isbn><eisbn>3318011630</eisbn><eisbn>9783318011630</eisbn><abstract>Introduction: More than half the patients with gastroesophageal reflux disease (GERD) show no endoscopic abnormality or minimal change esophagitis (non-erosive reflux disease, NERD). We investigated the value of endoscopic and histological markers for the prediction of NERD before and after treatment with 20 mg esomeprazole. Methods: Between July and October 2002, consecutive patients presenting for upper endoscopy were stratified into GERD and non-reflux patients (control group) with the help of a questionnaire. The endoscopist was blind to the presence of reflux symptoms. Using magnifying endoscopes minimal change esophagitis was defined by the presence of vascular injection or vascular spots above the Z-line, villous mucosal surface and islands of squamous cell epithelium below the Z-line. Targeted and random biopsies were taken below and above the Z-line. Patients with endoscopically visible classical signs of esophagitis (Los Angeles A–D) or histologically proven Barrett’s esophagus were not further investigated in the study (drop out). The esophageal specimens were histologically evaluated for erosions, infiltration with leukocytes, hyperplasia of basal cells and length of papillae. Patients with NERD were treated with 20 mg esomeprazole/day for 4 weeks and reevaluated by endoscopy as described before. Results: 39 patients with heartburn and 39 patients without reflux symptoms (controls) were finally included in the analysis (per protocol). Patients with NERD significantly (p = 0.005) more often showed endoscopic signs of minimal change esophagitis (27/39) than the control group (8/39). An increased length of papillae (14/39 versus 2/39; p = 0.005) and basal cell hyperplasia (17/39 versus 4/39; p = 0.009) were significantly more common in the heartburn group. After treatment with esomeprazole, no significant endoscopic or histological differences between the NERD and control group could be observed. Conclusions: Minimal change esophagitis can be seen with high resolution magnifying endoscopy. By combining endoscopic and histological markers NERD can be predicted with a sensitivity of 62% and a specificity of 74%. Treatment with esomeprazole for 4 weeks reverses the slight alterations to normal.</abstract><cop>Basel, Switzerland</cop><pmid>15383765</pmid><doi>10.1159/000080323</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0257-2753
ispartof Digestive diseases (Basel), 2004-01, Vol.22 (2), p.221-227
issn 0257-2753
1421-9875
language eng
recordid cdi_pubmed_primary_15383765
source MEDLINE; Karger Journals; Alma/SFX Local Collection
subjects Anti-Ulcer Agents - administration & dosage
Anti-Ulcer Agents - therapeutic use
Biopsy - methods
Case-Control Studies
Enzyme Inhibitors - administration & dosage
Enzyme Inhibitors - therapeutic use
Esomeprazole - administration & dosage
Esomeprazole - therapeutic use
Esophagitis - diagnosis
Esophagitis - drug therapy
Esophagitis - pathology
Esophagoscopy - methods
Female
Humans
Male
Middle Aged
Original Paper
Predictive Value of Tests
Prospective Studies
Proton Pump Inhibitors
Sensitivity and Specificity
title Minimal Change Esophagitis: Prospective Comparison of Endoscopic and Histological Markers between Patients with Non-Erosive Reflux Disease and Normal Controls Using Magnifying Endoscopy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T05%3A00%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Minimal%20Change%20Esophagitis:%20Prospective%20Comparison%20of%20Endoscopic%20and%20Histological%20Markers%20between%20Patients%20with%20Non-Erosive%20Reflux%20Disease%20and%20Normal%20Controls%20Using%20Magnifying%20Endoscopy&rft.jtitle=Digestive%20diseases%20(Basel)&rft.au=Kiesslich,%20R.&rft.date=2004-01-01&rft.volume=22&rft.issue=2&rft.spage=221&rft.epage=227&rft.pages=221-227&rft.issn=0257-2753&rft.eissn=1421-9875&rft.isbn=9783805578493&rft.isbn_list=3805578490&rft_id=info:doi/10.1159/000080323&rft_dat=%3Cproquest_pubme%3E66901253%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&rft.eisbn=3318011630&rft.eisbn_list=9783318011630&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=66901253&rft_id=info:pmid/15383765&rfr_iscdi=true